Related Experiment Video

Updated: Oct 15, 2025

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.4K

Correction: Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer

Dongyan Liu1,2,3, Xiaonan Hou4, Wangyu Wu5

  • 1Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.

Cell Death & Disease
|October 27, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.8K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.8K

Related Experiment Videos

Last Updated: Oct 15, 2025

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.4K
Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.8K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.8K

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K

Articles linked to this work by shared authors, journal, and citation graph.

Multi-Channel Postoperative MRI and Deep Transfer Learning to Distinguish Glioblastoma Recurrence from Pseudo-Progression: A Proof-of-Concept Study.

Cancers·2026

BCLXL blockade rewires cell fate to overcome PARP inhibitor resistance in ovarian cancer.

Signal transduction and targeted therapy·2026

Research Progress on Tumor Microenvironment-Responsive siRNA Nanocarriers: Design Strategies, Delivery Efficiency, and Future Perspectives.

International journal of nanomedicine·2026

π conjugation driven bulk and interfacial charge modulation in triazine based and heptazine based COF@ZnIn2S4 heterojunctions for efficient uranium removal.

Environmental research·2026

A new core-genome MLST approach for Chlamydia trachomatis genomic surveillance and research.

Nature communications·2026

Condensation of MATCAP promotes CENP-E-dependent chromosome congression in mitosis.

Nature communications·2026

Chondroitin sulfate shapes the unfolded protein response in osteosarcoma to sustain cancer cell survival during ER stress.

Cell death & disease·2026

Galectin-3 restrains T cell-driven inflammation in the testis and epididymis.

Cell death & disease·2026

Caspase-3 regulates RNA splicing and mitochondrial dynamics in microglia during Parkinson's disease.

Cell death & disease·2026

Non-canonical signaling hubs upon inhibition of MyD88-ERK interaction in cancer.

Cell death & disease·2026

The KAT8-CDK1 K33 acetylation axis drives doxorubicin resistance by suppressing ferroptosis and apoptosis in breast cancer.

Cell death & disease·2026

Targeting EHMT2 enhances NK cell maturation and antitumor activity.

Cell death & disease·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us